Short Interest in iShares Health Innovation Active ETF (NYSEARCA:BMED) Decreases By 39.2%

iShares Health Innovation Active ETF (NYSEARCA:BMED) saw a large decline in short interest in July. As of July 15th, there was short interest totaling 1,114 shares, a decline of 39.2% from the June 30th total of 1,831 shares. Approximately 0.3% of the company’s stock are sold short. Based on an average daily volume of 3,283 shares, the short-interest ratio is presently 0.3 days.

Institutional Trading of iShares Health Innovation Active ETF

A hedge fund recently bought a new stake in iShares Health Innovation Active ETF stock. Sunbelt Securities Inc. purchased a new stake in shares of iShares Health Innovation Active ETF (NYSEARCA:BMED) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 11,612 shares of the company’s stock, valued at approximately $352,000. Sunbelt Securities Inc. owned approximately 3.63% of iShares Health Innovation Active ETF at the end of the most recent reporting period.

iShares Health Innovation Active ETF Stock Up 0.0%

iShares Health Innovation Active ETF stock traded up $0.01 during trading hours on Thursday, hitting $31.25. The stock had a trading volume of 171 shares, compared to its average volume of 3,566. The stock’s 50-day moving average price is $29.62 and its 200-day moving average price is $29.61. The stock has a market capitalization of $11.25 million, a P/E ratio of 24.91 and a beta of 0.73. iShares Health Innovation Active ETF has a 12-month low of $24.50 and a 12-month high of $32.19.

iShares Health Innovation Active ETF Company Profile

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.